TRIMETAZIDINE SR 35 MG Overview
Trimetazidine SR 35 mg is a medication manufactured by Agron Remedies and falls under the category of uncategorized medicines. It is available in a strip packaging containing 10 tablets. The actual MRP of Trimetazidine SR 35 mg is Rs. 90, but it is currently being offered at a discounted price of Rs. 61.5, providing a discount of 31.67%.
Active Ingredients
The active ingredient in Trimetazidine SR 35 mg is Trimetazidine dihydrochloride, which is a specific inhibitor of the cellular sodium/potassium pump.
Pharmacological Properties
Trimetazidine works by improving the cellular metabolism in the heart muscle by optimizing the use of energy substrates. It helps in reducing the oxygen requirements of the heart muscle and improving its efficiency. This makes Trimetazidine beneficial in conditions where there is inadequate blood supply to the heart muscle.
Indications
Trimetazidine SR 35 mg is indicated for the treatment of angina pectoris, a condition characterized by chest pain or discomfort due to coronary artery disease. It is used as an adjunct to other angina medications in patients who do not adequately respond to standard treatments.
Contraindications
Trimetazidine SR 35 mg is contraindicated in patients with known hypersensitivity to trimetazidine or any other ingredients present in the formulation. It should not be used in patients with severe renal impairment or in pregnant or lactating women unless clearly needed.
Dosage
The usual recommended dose of Trimetazidine SR 35 mg is one tablet taken orally twice daily, preferably before meals. The dosage may vary depending on the severity of the condition and the individual response to the treatment. It is important to follow the dosing instructions provided by the healthcare provider.
Side Effects
Common side effects of Trimetazidine SR 35 mg may include headache, dizziness, gastrointestinal disturbances, and allergic skin reactions. In rare cases, it may cause serious side effects such as muscle disorders or neurological symptoms. Patients should seek immediate medical attention if they experience any severe side effects.
Drug Interactions
Trimetazidine may interact with certain medications such as antiarrhythmics, beta-blockers, and calcium channel blockers. It is important to inform the healthcare provider about all the medications, supplements, and herbal products being taken to avoid potential drug interactions.
Patient Counseling
Patients should be advised to take Trimetazidine SR 35 mg exactly as prescribed by the healthcare provider. They should not alter the dosage or discontinue the medication without consulting the healthcare provider. It is important to follow a healthy lifestyle, including a balanced diet and regular exercise, to maximize the effectiveness of the treatment.
Clinical Evidence
Several clinical studies have demonstrated the efficacy of Trimetazidine SR 35 mg in improving the symptoms of angina pectoris and enhancing the quality of life in patients with coronary artery disease. The medication has shown to be well-tolerated with a favorable safety profile in various patient populations.
Frequently Asked Questions (FAQs)
1. What is Trimetazidine SR 35 mg used for?
Trimetazidine SR 35 mg is used for the treatment of angina pectoris, a condition characterized by chest pain or discomfort due to coronary artery disease.
2. How should Trimetazidine SR 35 mg be taken?
The usual recommended dose of Trimetazidine SR 35 mg is one tablet taken orally twice daily, preferably before meals. Follow the dosing instructions provided by the healthcare provider.
3. Are there any common side effects of Trimetazidine SR 35 mg?
Common side effects of Trimetazidine SR 35 mg may include headache, dizziness, gastrointestinal disturbances, and allergic skin reactions.
4. Can Trimetazidine SR 35 mg interact with other medications?
Trimetazidine may interact with certain medications such as antiarrhythmics, beta-blockers, and calcium channel blockers. Inform your healthcare provider about all the medications you are taking.
5. Is Trimetazidine SR 35 mg safe for pregnant or lactating women?
Trimetazidine SR 35 mg should not be used in pregnant or lactating women unless clearly needed. Consult your healthcare provider for more information.
6. How long does it take to see the effects of Trimetazidine SR 35 mg?
The onset of action of Trimetazidine SR 35 mg may vary among individuals. It is important to continue the medication as prescribed and follow up with the healthcare provider for monitoring.
7. Can Trimetazidine SR 35 mg be used in patients with kidney problems?
Trimetazidine SR 35 mg should be used with caution in patients with kidney problems. The dosage may need to be adjusted based on the renal function of the patient.
8. What should I do if I miss a dose of Trimetazidine SR 35 mg?
If you miss a dose of Trimetazidine SR 35 mg, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and continue with the regular dosing schedule. Do not take double the dose to make up for the missed one.
9. Can Trimetazidine SR 35 mg be used in children?
Trimetazidine SR 35 mg is not recommended for use in children unless prescribed by a healthcare provider. The safety and efficacy of this medication in pediatric populations have not been established.
10. Is it safe to drive or operate machinery while taking Trimetazidine SR 35 mg?
Trimetazidine SR 35 mg may cause dizziness as a side effect. Patients should avoid driving or operating machinery if they experience this side effect until they are sure of how the medication affects them.
By providing comprehensive information on Trimetazidine SR 35 mg, patients can make informed decisions about its use and optimize the benefits of this medication for the treatment of angina pectoris. It is essential to consult with a healthcare provider for personalized recommendations and monitoring during the course of treatment with Trimetazidine SR 35 mg.
